These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10828887

  • 1. Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation.
    Bernardi R, Liebermann DA, Hoffman B.
    Oncogene; 2000 May 11; 19(20):2447-54. PubMed ID: 10828887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulatory roles of ubiquitin-proteasome pathway in pig oocyte meiotic maturation and fertilization.
    Sun QY, Fuchimoto D, Nagai T.
    Theriogenology; 2004 Jul 11; 62(1-2):245-55. PubMed ID: 15159117
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA, Fernandes KM, Morrison RF.
    J Cell Physiol; 2007 Apr 11; 211(1):101-11. PubMed ID: 17096381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T, Takata Y, Kagawa S, Roth JA, Tschopp J, Tanaka N.
    Oncogene; 2001 Aug 23; 20(37):5225-31. PubMed ID: 11526513
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.
    Pereg Y, Liu BY, O'Rourke KM, Sagolla M, Dey A, Komuves L, French DM, Dixit VM.
    Nat Cell Biol; 2010 Apr 23; 12(4):400-6. PubMed ID: 20228808
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
    Amir R, Ciechanover A, Cohen S.
    Harefuah; 2001 Dec 23; 140(12):1172-6, 1229. PubMed ID: 11789303
    [Abstract] [Full Text] [Related]

  • 16. p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A.
    Rother K, Kirschner R, Sänger K, Böhlig L, Mössner J, Engeland K.
    Oncogene; 2007 Mar 22; 26(13):1949-53. PubMed ID: 17001315
    [Abstract] [Full Text] [Related]

  • 17. Proteasome-dependent degradation of human CDC25B phosphatase.
    Cans C, Ducommun B, Baldin V.
    Mol Biol Rep; 1999 Apr 22; 26(1-2):53-7. PubMed ID: 10363647
    [Abstract] [Full Text] [Related]

  • 18. [Proteolytic enzyme and cell cycle regulation].
    Tanaka K.
    Tanpakushitsu Kakusan Koso; 1993 Jul 22; 38(9):1520-6. PubMed ID: 8395069
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint.
    Goloudina A, Yamaguchi H, Chervyakova DB, Appella E, Fornace AJ, Bulavin DV.
    Cell Cycle; 2003 Jul 22; 2(5):473-8. PubMed ID: 12963847
    [Abstract] [Full Text] [Related]

  • 20. Changes in proteasome localization during the cell cycle.
    Palmer A, Mason GG, Paramio JM, Knecht E, Rivett AJ.
    Eur J Cell Biol; 1994 Jun 22; 64(1):163-75. PubMed ID: 7957305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.